Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

Well, I'll put my faith in Dr. Mason. This quote refers to the combo trial Dr. Mason is/was running. Not saying some sort of cardiac toxicity may not one day show up here but, for now, who do you believe, a respected doctor or a poster on the board...

"On Monday, April 20, Nicola J. Mason, BVetMed, Ph.D., DACVIM, Assistant Professor of Medicine, University of Pennsylvania's School of Veterinary Medicine, presented preliminary data from an ongoing Phase 1 clinical study of 10 companion dogs with osteosarcoma (Poster Board #7; Abstract #LB-113). The data suggests that ADXS31-164 in combination with palliative radiation delayed tumor progression and prolonged overall survival in pet dogs with spontaneous osteosarcoma that were not candidates for primary tumor removal (amputation). Repeat doses of ADXS-HER2 were well tolerated with no systemic or cardiac toxicity."